U.S. Markets closed

AMAG Pharmaceuticals tops Street 4Q forecasts

WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Tuesday reported fourth-quarter net income of $3.5 million, after reporting a loss in the same period a year earlier.

The Waltham, Massachusetts-based company said it had profit of 10 cents per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 58 cents per share.

The specialty drugmaker posted revenue of $158.3 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $157.2 million.

For the year, the company reported that its loss widened to $199.2 million, or $5.71 per share. Revenue was reported as $610 million.

AMAG Pharmaceuticals expects full-year revenue in the range of $500 million to $560 million.

AMAG Pharmaceuticals shares have climbed 46 percent since the beginning of the year. The stock has decreased 18 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMAG at https://www.zacks.com/ap/AMAG